Syndax Pharmaceuticals

Syndax Pharmaceuticals

Biotechnology Research

Waltham, MA 19,529 followers

About us

Syndax Pharmaceuticals is a commercial stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Highlights of the Company's pipeline include revumenib a highly selective menin inhibitor, and Niktimvo™ (axatilimab-csfr), a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment for both revumenib and Niktimvo. Syndax corporate headquarters are in Waltham, MA.

Website
http://www.syndax.com
Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Waltham, MA
Type
Public Company

Locations

  • Primary

    35 Gatehouse Drive

    Building D, Floor 3

    Waltham, MA 02451, US

    Get directions

Employees at Syndax Pharmaceuticals

Updates

Similar pages

Browse jobs

Funding

Syndax Pharmaceuticals 15 total rounds

Last Round

Post IPO equity

US$ 230.0M

See more info on crunchbase